364 related articles for article (PubMed ID: 17110034)
1. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
Shinoda K; Hruby VJ; Porreca F
Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
[TBL] [Abstract][Full Text] [Related]
2. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
3. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
4. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
[TBL] [Abstract][Full Text] [Related]
5. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
6. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
Zhao M; Wang JY; Jia H; Tang JS
Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
[TBL] [Abstract][Full Text] [Related]
7. Relative contribution of peripheral versus central opioid receptors to antinociception.
Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
9. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury.
Guan Y; Johanek LM; Hartke TV; Shim B; Tao YX; Ringkamp M; Meyer RA; Raja SN
Pain; 2008 Aug; 138(2):318-329. PubMed ID: 18276075
[TBL] [Abstract][Full Text] [Related]
10. Analgesic properties of loperamide differ following systemic and local administration to rats after spinal nerve injury.
Chung C; Carteret AF; McKelvy AD; Ringkamp M; Yang F; Hartke TV; Dong X; Raja SN; Guan Y
Eur J Pain; 2012 Aug; 16(7):1021-32. PubMed ID: 22508374
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
12. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
13. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
[TBL] [Abstract][Full Text] [Related]
14. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain.
Wang JY; Zhao M; Huang FS; Tang JS; Yuan YK
Neurochem Res; 2008 Oct; 33(10):2134-41. PubMed ID: 18473169
[TBL] [Abstract][Full Text] [Related]
16. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury.
Komatsu T; Katsuyama S; Uezono Y; Sakurada C; Tsuzuki M; Hamamura K; Bagetta G; Sakurada S; Sakurada T
Neurosci Lett; 2018 Nov; 686():127-132. PubMed ID: 30201308
[TBL] [Abstract][Full Text] [Related]
18. Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
Menéndez L; Juárez L; García V; Hidalgo A; Baamonde A
Neuropharmacology; 2007 Jul; 53(1):71-80. PubMed ID: 17543351
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
[TBL] [Abstract][Full Text] [Related]
20. The role of delta-opioid receptor subtypes in neuropathic pain.
Mika J; Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Mar; 415(1):31-7. PubMed ID: 11245849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]